Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · IEX Real-Time Price · USD
8.52
0.00 (0.00%)
At close: Apr 26, 2024, 4:00 PM
8.54
+0.02 (0.23%)
After-hours: Apr 26, 2024, 5:13 PM EDT
Mind Medicine (MindMed) Market Cap
Mind Medicine (MindMed) has a market cap or net worth of $600.67 million as of April 26, 2024. Its market cap has increased by 314.25% in one year.
Market Cap
600.67M
Enterprise Value
518.62M
1-Year Change
314.25%
Ranking
Category
Stock Price
$8.52
Market Cap Chart
Since December 31, 2020, Mind Medicine (MindMed)'s market cap has decreased from $935.40M to $600.67M, a decrease of -35.78%. That is a compound annual growth rate of -12.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 352.20M | 0.71% |
| Apr 24, 2024 | 349.70M | -4.61% |
| Apr 23, 2024 | 366.60M | 2.17% |
| Apr 22, 2024 | 358.80M | - |
| Apr 19, 2024 | 358.80M | -2.58% |
| Apr 18, 2024 | 368.30M | -6.50% |
| Apr 17, 2024 | 393.90M | -3.55% |
| Apr 16, 2024 | 408.40M | 1.04% |
| Apr 15, 2024 | 404.20M | 1.13% |
| Apr 12, 2024 | 399.70M | -5.66% |
| Apr 11, 2024 | 423.70M | -5.95% |
| Apr 10, 2024 | 450.50M | 8.45% |
| Apr 9, 2024 | 415.40M | -7.71% |
| Apr 8, 2024 | 450.10M | -1.01% |
| Apr 5, 2024 | 454.70M | 1.86% |
| Apr 4, 2024 | 446.40M | -8.09% |
| Apr 3, 2024 | 485.70M | 19.31% |
| Apr 2, 2024 | 407.10M | 3.46% |
| Apr 1, 2024 | 393.50M | 1.29% |
| Mar 28, 2024 | 388.50M | -1.07% |
| Mar 27, 2024 | 392.70M | -3.66% |
| Mar 26, 2024 | 407.60M | -5.45% |
| Mar 25, 2024 | 431.10M | 6.66% |
| Mar 22, 2024 | 404.20M | 0.20% |
| Mar 21, 2024 | 403.40M | -1.22% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Pennant Group | 609.56M |
| Immunome | 609.33M |
| Stoke Therapeutics | 606.24M |
| Cross Country Healthcare | 604.23M |
| Aerovate Therapeutics | 601.00M |
| Embecta | 598.82M |
| HilleVax | 597.40M |
| Fulgent Genetics | 596.59M |